Alexion Archives - KingfirthHealthandFitness

28/10/2020

Alexion Receives FDA Approval for New Advanced Formulation of Ultomiris (ravulizumab-cwvz) with Significantly Reduced Infusion Time

BOSTON–(BUSINESS WIRE)–Oct. 12, 2020– Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (FDA) has approved Ultomiris